Mandate

Vinge advises Brummer & Partners in connection with its investment in Saltside Technologies AB

January 29, 2015

Vinge advises Frontier PE (Cayman) L.P., a fond managed by Brummer & Partners, in connection with its investment in Saltside Technologies AB together with Kinnevik and Hillhouse Capital. Saltside Technologies AB operates the leading online horizontal classifieds platforms in three frontier markets through Bikroy (Bangladesh), Ikman (Sri Lanka) and Tonaton (Ghana). All three platforms are market leaders in terms of user base, engagement and monetization. The headquarters are located in Dubai and the group has over 200 employees to date. Frontier PE (Cayman) L.P. is a private equity fund based in Bangladesh and managed by Brummer & Partners, a leading European manager of hedge funds. Brummer & Partners manages 125 billion SEK on behalf of private persons, corporations and institutional investors.

The Vinge team advising Frontier PE (Cayman) L.P. includes partners Christina Kokko and Johan Larsson together with associates Maria Dahlin, Karin Virding and Nicklas Thorgerzon.

Related

Vinge has advised Morrow Bank AB (publ) in conjunction with the acquisition of MedMera Bank AB

Vinge has advised Morrow Bank AB (publ) in conjunction with the acquisition of all shares in MedMera Bank AB from Kooperativa Förbundet for a total consideration of SEK 1,960 million. The transaction positions Morrow Bank as a leading Nordic platform in consumer finance with combined gross loans of SEK 28.2 billion.
March 24, 2026

Vinge advises NEWS, a portfolio company of Litorina, in connection with the sale of Skandinavisk Kommunalteknik, FANN VA-Teknik and Alunda Polyeten to Wienerberger AG

Vinge advises Northern Environmental and Water Solutions AB (“NEWS”), a portfolio company of Litorina, in connection with the sale of the operating subsidiaries Skandinavisk Kommunalteknik, FANN VA-Teknik and Alunda Polyeten to Wienerberger AG (Vienna Stock Exchange: WIE). The transaction is expected to be completed in Q2 2026.
March 24, 2026

Vinge has advised Hansa Biopharma in connection with entering into a financing agreement

Vinge has advised Hansa Biopharma AB (publ), a commercial-stage biopharmaceutical company on a mission to develop and commercialize innovative, lifesaving and life-altering treatments for patients with rare immunological conditions, listed on Nasdaq Stockholm, in connection with a U.S. convertible note purchase agreement comprising USD 30 million aggregate principal amount of unsecured convertible senior notes.
March 23, 2026